A linear particle accelerators are known to have broad range of therapys, in healthcare, linear particle accelerators are used for in the radiation therapy for the treatment of cancer. With advancements in the technology, precise accelerators have been developed that focus more on the damaged cells and tissues by means of radiation.
Due to the COVID-19 pandemic, the global Linear Particle Accelerators market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Linear Particle Accelerators market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Linear Particle Accelerators landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The increase in the prevalence of cancer and increase in the research and development activities is expected to drive the demand for linear particle accelerators market in the coming years. Increase in the number of players in the linear particle accelerators market is expected to provide a competitive market scenario during the forecast period.
This report focuses on Linear Particle Accelerators volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Linear Particle Accelerators market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Linear Particle Accelerators Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Low-Energy
High-Energy
Segment by Application
Hospitals
Clinics
Research Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Varian Medical Systems
Elekta Group
Accuray Incorporated
Sameer
Carl Zeiss
Siemens Healthcare
Brainlab AG
Laird Technologies
Altair Technologies
MedAustron
Sordina Iort Technologies
SHINVA Medical Instrument
AccSys Technology